In this podcast, hear from the world’s leading clinical psychedelic researchers on the latest science for how psychedelics can be effective therapies for difficult-to-treat physical conditions like fibromyalgia, chronic-Lyme disease and phantom-limb pain.
Read moreAwe and Psychedelics
What makes the psychedelic experience so healing? It could be “awe”.
Read moreIs the Universe Conscious?
Science writer Annaka Harris, author of Conscious: A Brief Guide to the Fundamental Mystery of the Mind (2019) offers an interesting theory of consciousness, that the universe itself is conscious and its consciousness is, perhaps, the only reality.
Read moreConsciousness Connects Us
Theory suggests that consciousness is a quantum process, connecting us all to the entire universe.
Read moreIncubation and Creativity
The unconscious process that leads to creativity: how ‘incubation’ works.
The creativity process has been divided into four phases – including one where you need to let your unconscious do the work.
Read moreDeep Into the Unconscious
We are used to skimming the surface of our emotions, distracting ourselves with endless doing. To discover what we really need, we must move beyond the shallows and dive deep into the unconscious.
Read moreOur Connection to Nature
Human connection to nature has declined 60% in 200 years, study finds.
Professor Miles Richardson says people risk ‘extinction of experience’ in the natural world without new policies.
Read moreEating Disorders and Psychedelics
In a survey of over 5,200 people surveyed about their eating disorders, slightly more than 1000 said they’d used psychedelics in the last 12 months — and a qualitative analysis of responses from 200 of those participants, published in Journal of Eating Disorders, suggests that the drugs helped them.
Read morePsychedelics: Risks and Benefits
Public health professional and psychedelic harm reduction advocate Kristin Nash, whose college-aged son died while under the influence of psilocybin and LSD, argues that psychedelic risks must be made clear to the public.
Psilocybin Extends Cellular Lifespan
This research paper shows the first experimental evidence that psilocin (the active metabolite of psilocybin) treatment extends cellular lifespan and psilocybin treatment promotes increased longevity in aged mice, suggesting that psilocybin may be a potent geroprotective agent.
Read morePsilocybin, Brain Health and Longevity
In the second wave of psychedelic research, there are multiple trials taking place across the world.
This includes looking into their potential use to treat end-of-life anxiety and depression in the terminally ill (at the US’s John Hopkins University and NYU), for smoking cessation, alcoholism, anorexia, OCD, asthma, longevity and pain syndromes, as well as seven separate trials worldwide into the use of psilocybin to treat depression.
Read more